Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Belén Garijo López
CEOBelén Garijo López
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
102.90B
Market cap102.90B
Price-Earnings ratio
18.31
Price-Earnings ratio18.31
Dividend yield
4.01%
Dividend yield4.01%
Average volume
3.02M
Average volume3.02M
High today
$42.30
High today$42.30
Low today
$41.94
Low today$41.94
Open price
$43.34
Open price$43.34
Volume
61.35K
Volume61.35K
52 Week high
$52.68
52 Week high$52.68
52 Week low
$41.94
52 Week low$41.94

SNY News

TipRanks 3d
Sanofi price target lowered to EUR 95 from EUR 100 at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Sanofi (SNY) to EUR 95 from EUR 100 and keeps a Buy rating on the shares. Unlock powerful investing tools and...

Seeking Alpha 5d
Sanofi type 1 diabetes therapy Tzield approved in U.S. for stage 3 of the disease

The U.S. Food and Drug Administration has greenlighted Sanofi’s (SNY) type 1 diabetes therapy Tzield for expanded use in stage 3 of the disease under its accele...

Sanofi type 1 diabetes therapy Tzield approved in U.S. for stage 3 of the disease
TipRanks 6d
Sanofi Expands Global Employee Share Plan with 2026 Offering

Sanofi ( (SNY) ) has issued an announcement. In June 2026, Sanofi detailed Action 2026, its twelfth annual global employee stock purchase plan, underscoring a...

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

More SNY News

TipRanks 7d
Sanofi’s ARAVA Safety Study in Saudi Arabia: What Investors Should Know Now

Sanofi (SNYNF) announced an update on their ongoing clinical study. Sanofi Tracks Real-World Safety Awareness for ARAVA in Saudi Arabia The study, titled “Pos...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.